Celltrion
From WikiMD's Wellness Encyclopedia
Celltrion is a South Korean biopharmaceutical company headquartered in Incheon, South Korea. It was founded in 2002 by Jung Jin Seo. The company specializes in the development, manufacturing, and marketing of biosimilars and biopharmaceuticals. Celltrion is known for its innovative approach to biotechnology and has made significant contributions to the global healthcare industry.
History[edit | edit source]
Celltrion was established in 2002 with the aim of developing biosimilars, which are biologic medical products highly similar to already approved reference products. The company quickly gained recognition for its high-quality biosimilars and expanded its operations globally.
Products[edit | edit source]
Celltrion's product portfolio includes a range of biosimilars and biopharmaceuticals. Some of the notable products include:
- Remsima (infliximab): A biosimilar to Remicade, used to treat autoimmune diseases such as rheumatoid arthritis and Crohn's disease.
- Truxima (rituximab): A biosimilar to Rituxan, used in the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
- Herzuma (trastuzumab): A biosimilar to Herceptin, used in the treatment of HER2-positive breast cancer.
Research and Development[edit | edit source]
Celltrion invests heavily in research and development (R&D) to innovate and improve its product offerings. The company operates state-of-the-art R&D facilities and collaborates with various academic and research institutions to advance its biopharmaceutical technologies.
Global Presence[edit | edit source]
Celltrion has a strong global presence, with subsidiaries and partnerships in various countries. The company exports its products to numerous markets, including the United States, Europe, and Asia. Celltrion's global expansion strategy focuses on increasing accessibility to affordable biosimilars and improving healthcare outcomes worldwide.
Awards and Recognition[edit | edit source]
Celltrion has received numerous awards and accolades for its contributions to the biopharmaceutical industry. The company is recognized for its commitment to quality, innovation, and patient care.
See Also[edit | edit source]
- Biopharmaceutical
- Biosimilar
- Incheon
- Rheumatoid arthritis
- Crohn's disease
- Non-Hodgkin's lymphoma
- Chronic lymphocytic leukemia
- HER2-positive breast cancer
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.